Article
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.
Blood - 15 Jun 2003
Little Richard F, Pittaluga Stefania, Grant Nicole, Steinberg Seth M, Kavlick Mark F, Mitsuya Hiroaki, Franchini Genoveffa, Gutierrez Martin, Raffeld Mark, Jaffe Elaine S, Shearer Gene, Yarchoan Robert, Wilson Wyndham H
Abstract excerpt
The outcome of acquired immunodeficiency syndrome-related lymphomas (ARLs) has improved since the era of highly active antiretroviral therapy, but median survival remains low. We studied dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) with suspension of antiretroviral therapy in 39 newly diagnosed ARLs and examined protein expression profiles associated with drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.